BR112013001514A2 - vacina para influenza - Google Patents

vacina para influenza

Info

Publication number
BR112013001514A2
BR112013001514A2 BR112013001514A BR112013001514A BR112013001514A2 BR 112013001514 A2 BR112013001514 A2 BR 112013001514A2 BR 112013001514 A BR112013001514 A BR 112013001514A BR 112013001514 A BR112013001514 A BR 112013001514A BR 112013001514 A2 BR112013001514 A2 BR 112013001514A2
Authority
BR
Brazil
Prior art keywords
influenza vaccine
influenza
vaccine
Prior art date
Application number
BR112013001514A
Other languages
English (en)
Inventor
A D M E Osterhaus
Bror Morein
Karin Lövgren Bengtsson
Original Assignee
Erasmus University Rotterdam Medical Ct
Isconova Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45497080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013001514(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Erasmus University Rotterdam Medical Ct, Isconova Ab filed Critical Erasmus University Rotterdam Medical Ct
Publication of BR112013001514A2 publication Critical patent/BR112013001514A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BR112013001514A 2010-07-23 2011-07-25 vacina para influenza BR112013001514A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36698310P 2010-07-23 2010-07-23
PCT/SE2011/050968 WO2012011868A1 (en) 2010-07-23 2011-07-25 Influenza vaccine

Publications (1)

Publication Number Publication Date
BR112013001514A2 true BR112013001514A2 (pt) 2016-06-07

Family

ID=45497080

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013001514A BR112013001514A2 (pt) 2010-07-23 2011-07-25 vacina para influenza

Country Status (12)

Country Link
US (2) US10485863B2 (pt)
EP (2) EP3272359A1 (pt)
JP (2) JP6133207B2 (pt)
KR (2) KR20130095251A (pt)
CN (2) CN107281478B (pt)
AU (1) AU2011280259C1 (pt)
BR (1) BR112013001514A2 (pt)
CA (1) CA2805741C (pt)
NZ (1) NZ606087A (pt)
RU (1) RU2583297C2 (pt)
WO (1) WO2012011868A1 (pt)
ZA (1) ZA201300395B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG149684A1 (en) 2001-01-19 2009-02-27 Vironovative Bv A virus causing respiratory tract illness in susceptible animals
EP1576090A4 (en) 2002-02-21 2008-07-16 Medimmune Vaccines Inc METAPNEUMOVIRUS STRAINS AND THEIR USE IN VACCINE PREPARATIONS AND AS EXPRESSION VECTORS OF ANTIGENIC SEQUENCES
CN107281478B (zh) 2010-07-23 2022-04-01 诺瓦瓦克斯公司 流感疫苗
PL238555B1 (pl) * 2013-12-20 2021-09-06 Inst Biochemii I Biofizyki Polskiej Akademii Nauk Sposób wytwarzania hydrofilowej domeny hemaglutyniny wirusa H5
PL235555B1 (pl) 2014-06-24 2020-09-07 Inst Biotechnologii I Antybiotykow Wyizolowany i oczyszczony polipeptyd hemaglutyniny (HA ) wirusa grypy H5N1, kompozycja zawierająca polipeptyd i jej zastosowanie, przeciwciało wiążące się specyficznie z polipeptydem oraz sposób otrzymywania tego polipeptydu
IL257800B2 (en) 2015-09-03 2023-11-01 Novavax Inc Immune compositions with improved stability and immunogenicity
CN108103084B (zh) 2017-11-21 2020-06-26 浙江迪福润丝生物科技有限公司 区分免疫和感染动物h5亚型禽流感疫苗株及其制备方法和应用
WO2022034934A1 (ko) * 2020-08-10 2022-02-17 한국생명공학연구원 인플루엔자 바이러스 백신 조성물
WO2023018817A1 (en) * 2021-08-11 2023-02-16 Sanofi Pasteur Inc. Truncated influenza neuraminidase and methods of using the same
GB202209588D0 (en) 2022-06-29 2022-08-10 Plant Bioscience Ltd Methods and compositions

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1048586A (en) 1911-12-06 1912-12-31 Maurice F Richardson Spring-trap.
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
CA1331443C (en) 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
NZ230747A (en) 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
SE9600647D0 (sv) 1996-02-21 1996-02-21 Bror Morein Ny användning
WO2002074795A2 (en) * 2001-01-18 2002-09-26 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Oligomeric complexes of chimeric proteins with enhanced immunogenic potential
SE0202110D0 (sv) 2002-07-05 2002-07-05 Isconova Ab Iscom preparation and use thereof
US20090263470A1 (en) * 2004-05-28 2009-10-22 Beth-Ann Coller Vaccine Compositions Comprising Virosomes and a Saponin Adjuvant
WO2007022425A2 (en) 2005-08-16 2007-02-22 Hawaii Biotech, Inc. Influenza recombinant subunit vaccine
EP1938835A1 (en) * 2006-12-29 2008-07-02 Pevion Biotech AG Non-specific immunostimulating agents
US8778847B2 (en) 2007-06-13 2014-07-15 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Immunogenic peptides of influenza virus
CN101820904A (zh) 2007-10-12 2010-09-01 Csl有限公司 引起针对大流行性流感病毒的免疫应答的方法
GB0810305D0 (en) * 2008-06-05 2008-07-09 Novartis Ag Influenza vaccination
CN105753948A (zh) * 2008-07-08 2016-07-13 麦迪卡格公司 可溶性重组流感抗原
WO2010144797A2 (en) * 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
HUE030724T2 (en) * 2010-04-09 2017-06-28 Univ Utrecht Holding Bv Recombinant multimer influenza proteins
CN107281478B (zh) 2010-07-23 2022-04-01 诺瓦瓦克斯公司 流感疫苗

Also Published As

Publication number Publication date
NZ606087A (en) 2014-06-27
AU2011280259A1 (en) 2013-02-07
CA2805741A1 (en) 2012-01-26
JP2016190846A (ja) 2016-11-10
AU2011280259B8 (en) 2014-09-25
ZA201300395B (en) 2013-09-25
US20190388534A1 (en) 2019-12-26
AU2011280259A8 (en) 2013-02-28
CN107281478B (zh) 2022-04-01
US10736958B2 (en) 2020-08-11
EP2595653A4 (en) 2014-03-12
KR20130095251A (ko) 2013-08-27
CN103052401A (zh) 2013-04-17
WO2012011868A1 (en) 2012-01-26
JP6133207B2 (ja) 2017-05-24
JP2013533270A (ja) 2013-08-22
RU2013108067A (ru) 2014-08-27
US20130129770A1 (en) 2013-05-23
RU2583297C2 (ru) 2016-05-10
CN107281478A (zh) 2017-10-24
AU2011280259B2 (en) 2014-05-22
US10485863B2 (en) 2019-11-26
KR20170141268A (ko) 2017-12-22
EP2595653A1 (en) 2013-05-29
EP2595653B1 (en) 2017-06-28
AU2011280259C1 (en) 2018-06-07
KR102143105B1 (ko) 2020-08-11
CA2805741C (en) 2019-08-13
EP3272359A1 (en) 2018-01-24

Similar Documents

Publication Publication Date Title
DK3170508T3 (da) Vaccineformuleringer
BR112014000912A2 (pt) ventilador
BR112013001514A2 (pt) vacina para influenza
SMT201700110B (it) Composizione immunogena
DK2793937T3 (da) Vacciner mod HPV
SMT201600082B (it) Vaccino pcsk9
DK3072505T3 (da) Testosteronformuleringer
CO6940426A2 (es) Formulaciones farmacéuticas
SMT201700046B (it) Micobatterio ricombinante come vaccino
BR112014000015A2 (pt) formulação
EP2852396A4 (en) INFLUENZA VACCINE CONSTRUCTS
DE102012102142A8 (de) Gebläse
DK2635269T3 (da) Kombinationspræparat
BR112013008074A2 (pt) combinações farmacêuticas
BR112014012043A2 (pt) emplastro
CO7010828A2 (es) Preparación farmacéutica que comprende ߖciclodextrina sustituida
DK2686011T3 (da) Ipn-vaccine
FR2978048B1 (fr) Composition vaccinale contre le paludisme
FR2978964B1 (fr) Composition vaccinale anti-il-6
BR112013023576A2 (pt) composições e métodos para a terapia e diagnóstico de influenza
CO6960544A2 (es) Preparación de liberación sostenida
DK2672817T3 (da) Forbedrede insekticide formuleringer
FR2971524B1 (fr) Eclisse universelle
BR112014012044A2 (pt) emplasto
DE112012004426A5 (de) Lüfter

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]